[Discussion] handling is doing more work than we give it credit for
Something I keep coming back to: handling is doing more work than we give it credit for.
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
On the thin testing history in this board, and what to do about it.
Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.
What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.
Why purity and net content diverge, and why that is usually honest.
Purity by area percent is a relative measure of what the detector saw. Net peptide content subtracts counterion, water and residual solvent from the powder mass. For some compounds in this catalogue the gap between the two is large.
A vial can therefore be 99% pure and contain considerably less peptide by mass than the label weight suggests, with nothing wrong anywhere. The problem is not the chemistry; it is that people compare a purity figure from one supplier with a net content figure from another and conclude something about both. Ask which number you are being shown, every time.
Ask me anything specific. Anything general I will probably get wrong.
best — the order this archive was captured in
Independent result added to the log — there are very few on that compound.
catalogue depth is not the same as catalogue quality
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
the less-tested the compound, the more the identity test matters
This. Asking what reference standard was used separates a real analytical claim from a plausible-looking one.
Push back: handling advice from one compound does not transfer to another just because both are peptides.
if nobody has tested it here, that is a fact about us, not the compound
lyophilised and stored cold is the default for a reason
Disagree — that name refers to at least two different molecules depending on who is selling it. The thread needs to be specific.
the sequence is the product, everything else is packaging
research-use-only material is not approved for human use
Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.
net peptide content is where the surprises live
purity methods differ between compound classes
Yes. Nothing in this catalogue is approved for human use and the board should keep saying so.
- 1Disagree — that name refers to at least two different molecules depending on…8 comments in this branch · started by u/osman_ferrari
- 2For any compound with a thin testing history, identity is the first…6 comments in this branch · started by u/rania_salinas